MoonTag and plant-derived activation domains for improved genetic engineering

A novel programmable transcriptional activator that can work with plant-derived activation domains to enable precise and robust gene activation in plants.
Technology No. 2022-087, 2022-150
IP Status: PCT Pending, US Patent Pending; Application No. 18/862,329 and 18/708,411

Applications

  • Crop engineering
  • Engineered genetic incompatibility
  • Biotherapeutics

Key Benefits & Differentiators

  • Increased stability: The MoonTag system is more stable in transgenic plants compared to previous systems like SunTag
  • Plant-derived activation domains: New activation domains (DREB2, DOF1) outperform VP64 with up to 3 fold higher transcription activation
  • Temperature resilience: Functional across a broad range of growth temperatures which is essential for potential field applications.

Technology Overview

CRISPR-based transcriptional activators have revolutionized gene activation by enabling targeted overexpression of plant genes. SunTag, a second-generation system, activates transcription by recruiting multiple copies of an activation domain to its target promoters. Although SunTag is a strong activator, it is difficult to stably express in some species, thus limiting its applications. Additionally, CRISPR-Cas activators have traditionally relied on non-plant-derived activation domains, such as VP64, which has limited activation efficiency and poses potential regulatory challenges.

To address these problems, researchers at the University of Minnesota have developed a robust programmable transcriptional activator, MoonTag, and novel plant-derived activation domains DREB2 and DOF1. MoonTag uses a nanobody NbGP41 and a GP41 peptide pair to mediate the recruitment of the activation domain. MoonTag demonstrates strong performance in monocots (Setaria) and dicots (Arabidopsis and tomato) and functions across a broad temperature range, making it suitable for field applications. By incorporating plant-specific activation domains such as DREB2 and DOF1, MoonTag delivers up to threefold higher gene activation than VP64. With MoonTag’s enhanced stability and the exceptional activity of novel plant-derived activation domains, these tools represent a significant advancement in precise and robust genetic engineering of plants.

Phase of Development

TRL: 3-4
Successfully validated in transgenic Arabidopsis plants with observable phenotypic changes. Other species that MoonTag has been demonstrated in include: Setaria (grasses), corn, tomato, tobacco, pennycress, and camelina.

Desired Partnerships

This technology is now available for:
  • License
  • Sponsored research
  • Co-development

Please contact our office to share your business’ needs and learn more.

Researchers

  • Michael Smanski, PhD Associate Professor, Department of Biochemistry, Molecular Biology, and Biophysics
  • Daniel Voytas, PhD McKnight Presidential Endowed Professor, Department of Genetics, Cell Biology, and Development
Questions about this technology?